DIO3 and cancer: In the lung cancer cohort, 13 retrogenes showed decreased expression in cancer (RPL13AP17, HNRNPA1P33, SIRPAP1, AL136982.4, AL136452.1, AC084880.1, HMGN2P15, CDC20P1, AC022217.1, DIO3, HMGB3P10, BET1P1, and TMED10P2) [89].